These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity. Rosenoer VM; Mitchley BC; Roe FJ; Connors TA Cancer Res; 1966 Aug; 26(8 Pt 2):937-41. PubMed ID: 5212554 [No Abstract] [Full Text] [Related]
4. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents. Keller HJ; Keppler B; Schmähl D Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355 [TBL] [Abstract][Full Text] [Related]
5. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Crim JA; Petering HG Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520 [No Abstract] [Full Text] [Related]
6. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Petering HG; Buskirk HH; Crim JA Cancer Res; 1967 Jun; 27(6):1115-21. PubMed ID: 6027202 [No Abstract] [Full Text] [Related]
7. The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats. Németh L Neoplasma; 1971; 18(5):533-7. PubMed ID: 5119525 [No Abstract] [Full Text] [Related]
9. The effect of B vitamin and protein intake of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Crim JA; Buskirk HH; Petering HG Cancer Res; 1967 Jun; 27(6):1109-14. PubMed ID: 6027201 [No Abstract] [Full Text] [Related]
10. 6-Dimethylaminochrysene and other analogs of 4-(4-dimethylamino)stilbene. Bahner CT; Brotherton DH; Kinder H; Rich W; Watson SL; Zirkle J J Med Chem; 1969 Jul; 12(4):722. PubMed ID: 5793178 [No Abstract] [Full Text] [Related]
11. [Probit-analysis in the evaluation of the selectivity of antineoplastic effect of agents]. Iavorskaia NP Vopr Onkol; 1971; 17(8):90-4. PubMed ID: 5002550 [No Abstract] [Full Text] [Related]
12. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers]. Teichmann B Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339 [No Abstract] [Full Text] [Related]
13. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)]. Matthias M; Tanneberger S; Gummel H Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278 [No Abstract] [Full Text] [Related]
14. [STUDIES ON THE ANTINEOPLASTIC EFFECT OF CHLORBUTINPENICILLIN]. NAVASHIN SM; FOMINA IP; TERENTEVA TG Antibiotiki; 1964 Aug; 9():692-5. PubMed ID: 14239555 [No Abstract] [Full Text] [Related]
15. Some antitumor agents derived from benzaldehyde nitrogen mustards. Florvall L Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623 [No Abstract] [Full Text] [Related]
16. [Experimental studies of the combined effect of ionizing radiation and of the cytostatic drug Proresid]. Kärcher KH; Morita K Arztl Forsch; 1967 Dec; 21(12):456-63. PubMed ID: 4876563 [No Abstract] [Full Text] [Related]
17. Walker carcinosarcoma 256 in study of anticancer agents. II. Results. Everett J Cancer Res; 1966 Aug; 26(8 Pt 2):942-9. PubMed ID: 4224206 [No Abstract] [Full Text] [Related]
19. Nutritional factors in the design of more selective antitumor agents. Bertino R; Nixon PF Cancer Res; 1969 Dec; 29(12):2417-21. PubMed ID: 4905239 [No Abstract] [Full Text] [Related]
20. [The influence of various adaptogens on the development of transplantable tumors following laparotomy]. Iaremenko KV; Moskalik KG Vopr Onkol; 1971; 17(2):66-71. PubMed ID: 5567712 [No Abstract] [Full Text] [Related] [Next] [New Search]